Guardian Pharmacy Services, Inc. (GRDN)

Every figure this model derived for GRDN, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 13,416,000 PaymentsToAcquireProductiveAssets 2025-12-31
cash 89,807,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 254,668,000 AssetsCurrent 2026-06-30
current liabilities 154,043,000 LiabilitiesCurrent 2026-06-30
equity 257,642,000 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 2026-06-30
interest expense 631,000 InterestExpenseNonoperating 2026-06-30
ocf 98,856,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 1,463,406,000 Revenues 2026-06-30
sbc 10,229,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up GRDN on one particular measure came for.

RatioValue
cash operating margin8.13
current ratio1.65
current ratio reported1.65
fcf margin5.84
interest cover135.4
operating margin5.84
owner earnings margin5.14
revenue growth10.31
revenue growth per share10.31
roic38.48
rule of 4016.15
sbc pct revenue0.7

What to be careful about

What this model itself distrusts about GRDN's figures. Written by the derivation as it ran, not added afterwards.